Skip to main content
Medicamen Biotech Ltd. logo

Medicamen Biotech Ltd. — Investor Relations & Filings

Ticker · MEDICAMEQ ISIN · INE646B01010 LEI · 894500T0ULD27B7W4Y03 BSE.NS Manufacturing
Open in API
Filings indexed 277 across all filing types
Latest filing 2024-09-27 Regulatory Filings
Country IN India
Listing BSE.NS MEDICAMEQ

About Medicamen Biotech Ltd.

https://www.medicamen.com/

Medicamen Biotech Ltd. specializes in the research, development, and manufacturing of a diverse range of pharmaceutical formulations. The company operates manufacturing facilities compliant with international quality standards, including WHO-GMP. Its product portfolio encompasses various therapeutic segments such as oncology, cardiology, central nervous system, and anti-infectives, delivered through dosage forms like tablets, capsules, and liquid orals. A significant strategic focus is placed on its specialized oncology division, which develops complex generic formulations. The company serves global markets, leveraging its research and development capabilities to provide high-quality healthcare solutions. Its operations are supported by dedicated R&D centers focused on formulation development and process chemistry.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short announcement dated 27.09.2024, addressed to stock exchanges, referencing Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It informs about a scheduled meeting with an analyst/investor on September 30, 2024. The content is brief, does not contain any financial data, results, or detailed reports, and serves as an intimation or notification. It is not a financial report, earnings release, or management discussion. Given the short length (1321 characters) and the nature of the content (an announcement of a meeting with investors), it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2024-09-27 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled as "Voting Results of 31st Annual General Meeting (AGM) of Medicamen Biotech Limited" and references Regulation 44(3) of SEBI Listing Regulations, which pertains to disclosure of voting results. It contains detailed voting results for multiple resolutions passed at the AGM, including adoption of audited financial statements, dividend declaration, director appointments, and remuneration ratification. It also includes a Consolidated Scrutinizer's Report pursuant to the Companies Act and related rules, which is a formal report on the voting process and results. The document is dated September 27, 2024, immediately following the AGM held on September 26, 2024. The content is focused on the official announcement of voting outcomes from the AGM, not the AGM presentation materials themselves or the full annual report. The document length is about 15,000 characters, which is consistent with a detailed voting results announcement. Therefore, this document fits the category of "Declaration of Voting Results & Voting Rights Announcements" (DVA).
2024-09-27 English
Shareholders meeting
AGM Information Classification · 100% confidence The document is titled as the 'Summary of proceedings of the 31st Annual General Meeting (AGM)' of Medicamen Biotech Limited held on 26th September 2024. It details the conduct of the AGM, including the chairman's address, voting procedures, resolutions considered (such as adoption of audited financial statements, dividend declaration, director appointments, and auditor remuneration), and the conclusion of the meeting. The document does not contain the full financial statements or detailed financial performance data but rather summarizes the meeting's proceedings and outcomes. It also references compliance with SEBI regulations and Companies Act provisions related to AGMs. Given these characteristics, the document fits the category of AGM Information (AGM-R) rather than an Annual Report or Voting Results announcement. The document length (7,562 characters) supports it being a detailed summary rather than a brief announcement. Therefore, the appropriate classification is AGM Information (AGM-R).
2024-09-26 English
Spurt in Volume
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the National Stock Exchange of India seeking to clarify a query about significant price movement of the company's shares. It states that there are no reportable events or price sensitive information affecting the share price, and that the price increase is market driven. The document is a regulatory communication responding to an exchange query, not a financial report or announcement of results. It does not contain financial data, management discussion, or report publication. It is a compliance-related disclosure under SEBI regulations, fitting the category of a general regulatory filing.
2024-09-26 English
Trading Plan under PIT
Regulatory Filings
2024-09-18 English
Updates
Regulatory Filings Classification · 95% confidence The document is a short announcement informing stock exchanges about the receipt of an EU GMP Certification for a specific manufacturing facility of Medicamen Biotech Limited. It references a regulatory obligation (SEBI Listing Regulations) but does not contain financial data, management discussion, voting results, or detailed report content. It is an informational regulatory announcement about a certification event, not a financial report, management change, or shareholder meeting material. The document length is only 1268 characters, indicating it is a brief notice rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-09-11 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.